製品番号: HY-172620

LIB3S0280

カスタマーレビュー

Based on 1 Customer Validation

LIB3S0280 is a potent TBK1 inhibitor with an IC₅₀ value of 493.9 nM. LIB3S0280 exhibits better anticancer effects in pancreatic cancer cell lines with high TBK1 expression. LIB3S0280 inhibits TBK1 downstream signaling pathways, including PI3K/AKT and NF-κB. LIB3S0280 induces G2/M arrest, apoptosis and cellular senescence. LIB3S0280 can be used for pancreatic ductal adenocarcinoma (PDAC) research.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 99.89%
分子式: C₂₂H₂₅ClN₄O₅
分子量:460.91

保管条件:

Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month

LIB3S0280 構造式

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

IC₅₀ & Target^[1]

TBK1

493.9 nM (IC₅₀)

IKK アイソフォーム固有の製品をすべて表示 :

Akt アイソフォーム固有の製品をすべて表示 :

PI3K アイソフォーム固有の製品をすべて表示 :

NF-κB アイソフォーム固有の製品をすべて表示 :

CDK アイソフォーム固有の製品をすべて表示 :

Caspase アイソフォーム固有の製品をすべて表示 :

PARP アイソフォーム固有の製品をすべて表示 :

体外実験

LIB3S0280 (72-96 h) shows significant inhibition against high TBK1-expressing pancreatic cancer cell lines with the GI₅₀ values of 2.24 μM (MIA PaCa-2) and 4.71 μM (PANC-1) , and IC₅₀ values of 6.64 μM (MIA PaCa-2) and 10.98 μM (PANC-1) at 96 h^[1].
LIB3S0280 (10-20 μM, 3 h) inhibits TBK1 downstream signaling, including the PI3K/AKT and NF-κB pathways, by effectively reducing the phosphorylation of its key targets, AKT (Ser473) and IκBα, in MIA PaCa-2 and PANC-1 cells^[1].
LIB3S0280 (10-20 μM, 48-96 h) induces G₂/M arrest, apoptosis, and cellular senescence in pancreatic cancer cells (MIA PaCa-2 and PANC-1) by modulating key regulators like p-cdc2, p-MPM2, cyclin B1, and p21^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

MIA PaCa-2 and PANC-1 cells
Concentration:

10 and 20 μM
Incubation Time:

3, 48, 72 and 96 h
Result:

Decreased the phosphorylation of IκBα in a dose-dependent manner.
Reduced the phosphorylation level of AKT on the ser473 site.
Increased p21 levels from 48 h to 96 h.

Cell Viability Assay^[1]

Cell Line:

MIA PaCa-2, PANC-1, and SW1990 cells
Concentration:

10 μM
Incubation Time:

72 and 96 h
Result:

Significantly inhibited cell proliferation and cell viability in a concentration-dependent manner, with efficacy comparable to BX-795 (HY-10514).
Demonstrated greater potency against the MIA PaCa-2 cell line.
Showed no inhibition in SW1990 cells.

Cell Cycle Analysis^[1]

Cell Line:

MIA PaCa-2 and PANC-1 cells
Concentration:

10 and 20 μM
Incubation Time:

48, 72 and 96 h
Result:

Significantly increased the G2/M phase population and slightly increased the sub-G1 population at 48 h.
Downregulated the expression level of p-MPM2, and upregulated p-cdc2 (tyr15) and cyclin B1 levels after 48 h.
Slightly decreased the G2/M population but increased sub-G1 population at 72 h, compared to 48 h.
Exhibited a significant increase in the sub-G1 population and a further decrease in the G2/M phase at 96 h.

Apoptosis Analysis^[1]

Cell Line:

MIA PaCa-2 and PANC-1 cells
Concentration:

10 and 20 μM
Incubation Time:

48, 72 and 96 h
Result:

Induced apoptosis at 72-96 h.
Slightly increased cleaved PARP and cleaved caspase 3 levels after 48 h.
Increased the granularity in MIA PaCa-2 and PANC-1 cells at 48 h, 72 h, and 96 h.
Induced senescence in MIA PaCa-2 and PANC-1 cells.

化学情報

性状 Solid
分子量 460.91
分子式 C₂₂H₂₅ClN₄O₅
Color Off-white to gray
SMILES

OC1=C(OC)C=C(CCNC2=NC(NC3=CC(OC)=C(OC)C(OC)=C3)=NC=C2Cl)C=C1
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

DMSO : 50 mg/mL (108.48 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.1696 mL

10.8481 mL

21.6962 mL

5 mM

0.4339 mL

2.1696 mL

4.3392 mL

10 mM

0.2170 mL

1.0848 mL

2.1696 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (276 KB)
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Wan-Hsi Shih, et al. Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma. Int J Biol Macromol. 2024 Dec;283(Pt 1):137296. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.1696 mL	10.8481 mL	21.6962 mL	54.2405 mL
	5 mM	0.4339 mL	2.1696 mL	4.3392 mL	10.8481 mL
	10 mM	0.2170 mL	1.0848 mL	2.1696 mL	5.4241 mL
	15 mM	0.1446 mL	0.7232 mL	1.4464 mL	3.6160 mL
	20 mM	0.1085 mL	0.5424 mL	1.0848 mL	2.7120 mL
	25 mM	0.0868 mL	0.4339 mL	0.8678 mL	2.1696 mL
	30 mM	0.0723 mL	0.3616 mL	0.7232 mL	1.8080 mL
	40 mM	0.0542 mL	0.2712 mL	0.5424 mL	1.3560 mL
	50 mM	0.0434 mL	0.2170 mL	0.4339 mL	1.0848 mL
	60 mM	0.0362 mL	0.1808 mL	0.3616 mL	0.9040 mL
	80 mM	0.0271 mL	0.1356 mL	0.2712 mL	0.6780 mL
	100 mM	0.0217 mL	0.1085 mL	0.2170 mL	0.5424 mL

Keywords

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

LIB3S0280

Apoptosis Compound Library

Cell Cycle/DNA Damage Compound Library

Epigenetics Compound Library

Immunology/Inflammation Compound Library

Kinase Inhibitor Library

NF-κB Signaling Compound Library

PI3K/Akt/mTOR Compound Library

Stem Cell Signaling Compound Library

Anti-Cancer Compound Library

Autophagy Compound Library

Anti-Aging Compound Library

Antioxidant Compound Library

Differentiation Inducing Compound Library

Oxygen Sensing Compound Library

Glycolysis Compound Library

Pyroptosis Compound Library

Cytoskeleton Compound Library

Glutamine Metabolism Compound Library

Anti-Breast Cancer Compound Library

Anti-Lung Cancer Compound Library

Anti-Pancreatic Cancer Compound Library

Anti-Blood Cancer Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Obesity Compound Library

Angiogenesis-Related Compound Library

Mitochondria-Targeted Compound Library

Transcription Factor-Targeted Library

Glucose Metabolism Compound Library

Anti-Liver Cancer Compound Library

Anti-Colorectal Cancer Compound Library

Antidepressant Compound Library

Anti-Prostate Cancer Compound Library

Anti-Pulmonary Fibrosis Compound Library

Cancer Stem Cells Compound Library

Pain-Related Compound Library

Membrane Protein-targeted Compound Library

Cell Death Library

Serine/Threonine Kinase Inhibitor Library

Anti-Hematopathy Compound Library

Anti-Ovarian Cancer Compound Library

Multi-Target Compound Library

Radioprotector Library

Mitophagy Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Anti-Gastric Cancer Compound Library

Anti-Fibrosis Compound Library

Anti-Brain Cancer Compound Library

Protein Kinase Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

Cell Proliferation Compound Library

High-Throughput Bioactive Compound Library

Anti-Rheumatic Arthritis Compound Library

Lactylation Compound Library

IKK アイソフォーム固有の製品をすべて表示

Akt アイソフォーム固有の製品をすべて表示

PI3K アイソフォーム固有の製品をすべて表示

NF-κB アイソフォーム固有の製品をすべて表示

CDK アイソフォーム固有の製品をすべて表示

Caspase アイソフォーム固有の製品をすべて表示

PARP アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

LIB3S0280 関連分類

HY-172620 関連分類